Bausch Health wins ‘stalking horse’ bid to buy Synergy Pharmaceuticals for $195 million

Bausch Health's headquarters in Laval, Quebec.Ryan Remiorz/The Canadian Press

LAVAL, Que. — Bausch Health Companies Inc. has been selected as the winning bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for about $195 million plus certain liabilities.

The Quebec-headquartered pharmaceutical company formerly called Valeant Inc. had been the “stalking horse” bidder in a court-supervised auction and sale process.

Synergy, a U.S. maker of gastrointestinal therapies, filed for bankruptcy in December under Chapter 11.

Leave a Reply

Your email address will not be published. Required fields are marked *